Endoscopic study comparing gastroduodenal tolerability of piroxicam-β-cyclodextrin vs. piroxicam;Vergleichende endoskopische Untersuchung zur gastroduodenalen Vertraglichkeit von Piroxicam-β-Cyclodextrin vs Piroxicam

Zeitschrift fur Rheumatologie

Volumn 56, Issue 2, 1997, Pages 76-79

  Muller P ^a   Simon, B ^b  

^a Krankenhaus Salem   (Germany)

^b Kreiskrankenhaus Schwetzingen   (Germany)

Author keywords

endoscopy; gastroduodenal damage; non steroidal anti inflammatory drugs; piroxicam; piroxicam cyclodextrin

Indexed keywords

PIROXICAM; PIROXICAM BETA CYCLODEXTRIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; ENDOSCOPY; GASTROINTESTINAL TOXICITY; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; MALE; ORAL DRUG ADMINISTRATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DUODENUM; ENDOSCOPY, DIGESTIVE SYSTEM; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; MALE; PIROXICAM;

EID: 0030927559     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050023     Document Type: Article

References (11)

1. Ambanelli U, Nervetti A, Colombo B et al (1990) Piroxicam-β-cyclodextrin in the treatment of rheumatic diseases. A prospective study. Curr Ther Res 48:58-68
2. Cockel R (1987) NSAID's should every prescriptions carry a Government Health Warning? GUT 28:515-518
3. Grayson MF (1992) Interne Dokumentation, Pharmacia, 1992
4. Lanza, FL (1984) Endoscopie studies of gastric and duodenal injury after the use of ibuprofen, aspirine and non-steroidal anti-inflammatory agents. Am J Med 1 A: 19-24
5. Müller, P, Simon B (1992) Schutzwirkung von Ranitidin im Magen und Duodenum gegenüber Piroxicam: eine endoskopisch kontrollierte Doppelblindstudie. Arzneimittelforschung 32(II):1492-1494
6. Müller P, Leucht U, Simon B (1992) Hochdosiertes Ranitidin schützt Magen und Duodenum vollständig gegenüber Piroxicam: eine endoskopische Doppelblind-Pilotstudie. J Gastroenterol 30: 851-853
7. Rietbrock N, Woodcock BG (1992) Wertung der Expertenberichte zur pharmakologisch-toxikologischen und klinischen Dokumentation von Brexidol. Interne Dokumentation, Pharmacia
8. Santucci L, Fiorucci S, Patoia et al (1990) Gastric tolerance of piroxicam-β-cyclodextrin compared with placebo and with other NSAID's. An endoscopie and functional study by evaluation of transmucosal potential difference. Drug Invest 2/Supp 4:56-60
9. Santucci L, Fiorucci S, Pelli AM et al (1991) Macromolecular encapsulation as a protective factor against gastric disorders caused by non-steroidal anti-inflammatory drugs. J Drug Dev 4/Suppl 1: 27-37
10. SPALA (safety profile of antirheumatic longterm administration (1990) Sicherheitsprofil von Antirheumatika bei Langzeitanwendung. Dt Ärztebl 87(37)B - 1916 - B - 24
11. Warrington S, Debbas N, Farthing M et al (1991) Piroxicam-β-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men. Int Tiss Reac XIII/5:243-248